A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission. The findings from the ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

The immunotherapy protocol successfully treated 100% of rectal cancer patients involved in the trial. "My husband, Tommy, and I were preparing for the worst," recalled Maureen Sideris, who was ...

He thought the May 2023 race was his greatest physical challenge — until he was diagnosed with Stage 3 rectal cancer months later at the age of 47. “I eat a healthy diet. I exercise six days a ...

Preventing a cancer diagnosis is a top health goal for many – and what people eat and drink can potentially play a big role. Matcha, a type of green tea that's also a popular coffee alternative ...

That's when she was diagnosed with Stage 3 rectal cancer that had spread to her lymph nodes at Massachusetts General. “In an odd way, it was a relief because I knew I wasn’t crazy, and I felt ...

Colorectal cancer stands as the third leading cause of cancer-related deaths in US men and the fourth leading cause in US women, according to the American Cancer Society. This year, over 150,000 ...

A retrospective study of patients with distal rectal cancer at Memorial Sloan Kettering Cancer Center ... when the tumor involves the external sphincter complex, the distal margin is inadequate, ...

At 35, Katie Dutton is already a rectal cancer survivor, an ordeal that started with seemingly benign symptoms doctors initially dismissed. She was told to change her diet and was treated for ...

Dr. Garcia-Aguilar and the colorectal service at MSK are experts at the watch and wait approach to rectal cancer treatment, which can preserve a patient's quality of life by avoiding surgical removal ...

Jemperli received FDA breakthrough therapy designation for locally advanced dMMR/MSI-H rectal cancer, following a Fast Track designation in January 2023. The designation aims to expedite development ...

Further research is needed to evaluate long-term outcomes, efficiency, and cost-effectiveness of robotic APR in rectal cancer treatment ... resection margin and better short-term outcomes compared ...